For Indian parents navigating autism spectrum disorder (ASD) or drug-resistant epilepsy in their children, CBD oil has emerged as a topic of intense interest, and confusion. While purified, prescription-grade cannabidiol (CBD) is now conditionally approved in India for severe epilepsies like Dravet syndrome and Lennox–Gastaut syndrome, evidence for autism remains preliminary and largely...